Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeyondSpring Inc. Regulatory Filings 2024

Feb 2, 2024

34404_ffr_2024-02-02_77365ee6-c6c4-4a6c-bbd5-564392a62919.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2024

Commission File Number: 001-38024

BeyondSpring Inc.

BeyondSpring Inc. 100 Campus Drive, West Side, 4th Floor, Suite 410 Florham Park , New Jersey 07932 (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

On February 2, 2024, BeyondSpring Inc. (the “Company”) reported financial results for the six months ended June 30, 2023 .

As previously reported on Form 6-Ks filed by the Company on September 20, 2023 and January 16, 2024, Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”), the Company’s 58%-owned subsidiary in China, was party to an arbitration proceeding initiated by Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui”). On January 10, 2024, the arbitral tribunal at China International Economic and Trade Arbitration Committee issued a final award, denying all claims made by Hengrui.

As a result, all of Wanchunbulin’s assets that have been seized and frozen pending a decision by the arbitral tribunal are expected to be returned to Wanchunbulin. Such seized and frozen assets are reflected in the Company’s balance sheet as of June 30, 2023 as “Restricted Cash.”

This Report on Form 6-K is incorporated by reference into the Registration Statement on Form F-3, File No. 333-257639, and the Registration Statements on Form S-8, File No. 333-216639 and File No. 333-240082, of the Company.

BEYONDSPRING INC.

CONDENSED CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2022 AND JUNE 30, 2023

(Amounts in thousands of U.S. Dollars ($), except for number of shares and per share data)

$ $
(Unaudited)
Assets
Current assets:
Cash and cash equivalents 34,396 13,492
Restricted Cash - 9,736
Short-term investments 2,872 1,902
Advances to suppliers 492 444
Prepaid expenses and other current assets 763 217
Total current assets 38,523 25,791
Noncurrent assets:
Property and equipment, net 1,868 1,800
Operating lease right-of-use assets 5,484 4,946
Other noncurrent assets 347 341
Total noncurrent assets 7,699 7,087
Total assets 46,222 32,878
Liabilities and equity
Current liabilities:
Accounts payable 1,081 1,501
Accrued expenses 2,470 1,682
Current portion of operating lease liabilities 966 784
Deferred revenue 1,351 1,751
Other current liabilities 1,484 1,104
Total current liabilities 7,352 6,822
Noncurrent liabilities:
Operating lease liabilities 3,995 3,687
Deferred revenue 34,221 33,529
Other noncurrent liabilities 3,661 3,527
Total noncurrent liabilities 41,877 40,743
Total liabilities 49,229 47,565
Commitments and contingencies
Mezzanine equity
Contingently redeemable noncontrolling interests 11,074 11,474
Shareholders' deficit
Ordinary shares ($ 0.0001 par value; 500,000,000 shares authorized; 38,999,597 and 39,015,476 shares issued and outstanding as of December 31, 2022 and June 30, 2023, respectively) 4 4
Additional paid-in capital 368,857 368,679
Accumulated deficit ( 375,276 ) ( 387,996 )
Accumulated other comprehensive income 436 1,223
Total BeyondSpring Inc.’s shareholders’ deficit ( 5,979 ) ( 18,090 )
Noncontrolling interests ( 8,102 ) ( 8,071 )
Total shareholders' deficit ( 14,081 ) ( 26,161 )
Total liabilities, mezzanine equity and shareholders' deficit 46,222 32,878

BEYONDSPRING INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF

COMPREHENSIVE LOSS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023

(Amounts in thousands of U.S. Dollars ($), except for number of shares and per share data)

2022 2023
$ $
Revenue 676 875
Operating expenses
Research and development ( 13,992 ) ( 9,214 )
General and administrative ( 7,492 ) ( 5,145 )
Loss from operations ( 20,808 ) ( 13,484 )
Foreign exchange loss, net ( 350 ) ( 200 )
Interest income 41 281
Interest expenses ( 17 ) -
Other income, net 1,259 133
Loss before income tax ( 19,875 ) ( 13,270 )
Income tax expenses (benefits) ( 289 ) 9
Net loss ( 20,164 ) ( 13,261 )
Less: Net loss attributable to noncontrolling interests ( 1,675 ) ( 541 )
Net loss attributable to BeyondSpring Inc. ( 18,489 ) ( 12,720 )
Net loss per share
Basic and diluted ( 0.47 ) ( 0.33 )
Weighted-average shares outstanding
Basic and diluted 39,065,710 38,976,761
Other comprehensive loss, net of tax of nil:
Foreign currency translation adjustment 949 1,249
Unrealized holding gain (loss) 30 ( 5 )
Comprehensive loss ( 19,185 ) ( 12,017 )
Less: Comprehensive loss attributable to noncontrolling interests ( 1,336 ) ( 84 )
Comprehensive loss attributable to BeyondSpring Inc. ( 17,849 ) ( 11,933 )

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BeyondSpring Inc.
By: /s/ Lan Huang
Name: Lan Huang
Title: Chairperson and Chief Executive Officer

Date: February 2, 2024

EXHIBIT INDEX

Exhibit No. Exhibit
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)